Altimmune, Inc. (ALT)
1.535
-0.02
(-1.60%)
USD |
NASDAQ |
Nov 17, 16:00
1.55
+0.02
(+0.98%)
After-Hours: 20:00
Altimmune EPS Diluted (Quarterly) : -0.154 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.154 |
| June 30, 2026 | -0.1231 |
| March 31, 2026 | -0.1813 |
| December 31, 2025 | -0.2719 |
| September 30, 2025 | -0.2126 |
| June 30, 2025 | -0.2718 |
| March 31, 2025 | -0.2591 |
| December 31, 2024 | -0.3253 |
| September 30, 2024 | -0.3214 |
| June 30, 2024 | -0.3474 |
| March 31, 2024 | -0.3445 |
| December 31, 2023 | -0.5414 |
| September 30, 2023 | -0.3854 |
| June 30, 2023 | -0.3168 |
| March 31, 2023 | -0.4005 |
| December 31, 2022 | -0.433 |
| September 30, 2022 | -0.4771 |
| June 30, 2022 | -0.4233 |
| March 31, 2022 | -0.4419 |
| December 31, 2021 | -0.5728 |
| September 30, 2021 | -0.81 |
| June 30, 2021 | -0.6003 |
| March 31, 2021 | -0.382 |
| December 31, 2020 | -0.286 |
| September 30, 2020 | -0.5376 |
| Date | Value |
|---|---|
| June 30, 2020 | -0.9374 |
| March 31, 2020 | -0.2572 |
| December 31, 2019 | -0.2675 |
| September 30, 2019 | -0.7407 |
| June 30, 2019 | -0.258 |
| March 31, 2019 | -0.2687 |
| December 31, 2018 | -2.786 |
| September 30, 2018 | -1.731 |
| June 30, 2018 | -10.20 |
| March 31, 2018 | -7.50 |
| December 31, 2017 | -19.28 |
| September 30, 2017 | -61.50 |
| June 30, 2017 | -7.80 |
| March 31, 2017 | -204.00 |
| December 31, 2016 | -138.00 |
| September 30, 2016 | -213.00 |
| June 30, 2016 | -75.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Imunon, Inc. | -0.6412 |
| Taysha Gene Therapies, Inc. | -0.0964 |
| Agenus, Inc. | 0.0183 |
| Amgen, Inc. | 7.077 |
| Anika Therapeutics, Inc. | -0.0232 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -31.61M |
| Total Expenses (Quarterly) | 31.61M |
| Enterprise Value | 74.58M |
| Earnings Yield | -47.58% |
| Normalized Earnings Yield | -47.37 |